Search

Author/Creator Feagan, Brian

1. Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report. (November 2018)

Authors:
Lichtenstein, Gary; Feagan, Brian; Mahadevan, Uma; Salzberg, Bruce; Langholff, Wayne; Morgan, G.; Safdi, Michael; Nissinen, Riikka; Taillard, François; Sandborn, William; Cohen, Russell
Journal:
American journal of gastroenterology
Issue:
Volume 113:Number 11(2018)
Page Start:
1678
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis: A Post Hoc Analysis of GEMINI 1. Issue 4 (5th October 2018)

Authors:
Reinisch, Walter; Bressler, Brian; Curtis, Rebecca; Parikh, Asit; Yang, Huyuan; Rosario, Maria; Røseth, Arne; Danese, Silvio; Feagan, Brian; Sands, Bruce E; Ginsburg, Philip; Dassopoulos, Themistocles; Lewis, James; Xu, Jing; Wyant, Tim
Journal:
Inflammatory bowel diseases
Issue:
Volume 25:Issue 4(2019)
Page Start:
803
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 20 ETROLIZUMAB IMPROVED ENDOSCOPIC SCORE, PATIENT-REPORTED OUTCOMES, AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH MODERATE TO SEVERE UC WHO HAD FAILED TNF ANTAGONIST THERAPY: THE HICKORY OPEN-LABEL INDUCTION (OLI) COHORT. (18th January 2018)

Authors:
Peyrin-Biroulet, Laurent; Rubin, David T; Feagan, Brian; Oh, Young S; Arulmani, Udayasankar; Tyrrell, Helen; Maciuca, Romeo; Williams, Sarah; Tole, Swati; Thommes, James
Journal:
Inflammatory bowel diseases
Issue:
Volume 24(2018)Supplement 1
Page Start:
S12
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Performance of Crohn's disease Clinical Trial Endpoints based upon Different Cutoffs for Patient Reported Outcomes or Endoscopic Activity: Analysis of EXTEND Data. Issue 5 (14th April 2018)

Authors:
Feagan, Brian; Sandborn, William J; Rutgeerts, Paul; Levesque, Barrett G; Khanna, Reena; Huang, Bidan; Zhou, Qian; Maa, Jen-fue; Wallace, Kori; Lacerda, Ana; Thakkar, Roopal B; Robinson, Anne M
Journal:
Inflammatory bowel diseases
Issue:
Volume 24:Issue 5(2018)
Page Start:
932
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P046 HISTOLOGIC MEASURES OF MUCOSAL HEALING CORRELATE WITH ENDOSCOPIC MEASURES OF DISEASE ACTIVITY AT BASELINE AND FOLLOWING INDUCTION THERAPY WITH THE JANUS KINASE 1 INHIBITOR FILGOTINIB IN ACTIVE CROHN'S DISEASE: RESULTS FROM FITZROY STUDY. (18th January 2018)

Authors:
Reinisch, Walter; D'Haens, Geert; Hertogh, Gert De; Van der Aa, Annegret; Etchevers K, Kim; Tasset, Chantal; Yun, Chohee; Serone, Adrian; Feagan, Brian; Sandborn, William J; Vermeire, Séverine
Journal:
Inflammatory bowel diseases
Issue:
Volume 24(2018)Supplement 1
Page Start:
S16
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Systematic review: medical therapy for fibrostenosing Crohn's disease. Issue 12 (13th May 2020)

Authors:
Lu, Cathy; Baraty, Brandon; Lee Robertson, Helen; Filyk, Alexis; Shen, Hua; Fung, Tak; Novak, Kerri; Ma, Christopher; Panaccione, Remo; Achkar, Jean‐Paul; El Ouali, Sara; Bruining, David; Jairath, Vipul; Feagan, Brian; Rieder, Florian
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 51:Issue 12(2020)
Page Start:
1233
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Development of an index to define overall disease severity in IBD. Issue 2 (25th October 2016)

Authors:
Siegel, Corey A; Whitman, Cynthia B; Spiegel, Brennan M R; Feagan, Brian; Sands, Bruce; Loftus, Edward V; Panaccione, Remo; D'Haens, Geert; Bernstein, Charles N; Gearry, Richard; Ng, Siew C; Mantzaris, Gerassimos J; Sartor, Balfour; Silverberg, Mark S; Riddell, Robert; Koutroubakis, Ioannis E; O'...
Journal:
Gut
Issue:
Volume 67:Issue 2(2018)
Page Start:
244
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. PWE-071 Etrolizumab induction in moderate/severe anti-TNF intolerant/refractory (IR) UC: the hickory open-label induction (OLI) trial. (8th June 2018)

Authors:
Hayee, Bu'hussain; Rubin, David; Feagan, Brian; Oh, Young S; Arulmani, Udayasankar; Tyrrell, Helen; Maciuca, Romeo; Williams, Sarah; Tole, Swati; Thommes, James; Peyrin-Biroulet, Lauren
Journal:
Gut
Issue:
Volume 67(2018)Supplement 1
Page Start:
A102
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. S754 Risankizumab as Induction Therapy in Patients with Moderately to Severely Active Crohn's Disease Who Failed 1 vs >1 Prior Biologic Treatment: Results From the MOTIVATE Study. (October 2021)

Authors:
Panaccione, Remo; Schreiber, Stefan; Peyrin-Biroulet, Laurent; Loftus, Edward V.; Dubinsky, Marla; Ferrante, Marc; Song, Alexandra; Huang, Bidan; Liao, Xiaomei; Berg, Sofie; Duan, Weijiang R; Wallace, Kori; Feagan, Brian
Journal:
American journal of gastroenterology
Issue:
Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1
Page Start:
S348
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. S772 Risankizumab Therapy Induces Improvements in Endoscopic Endpoints in Patients With Moderate-To-Severe Crohn's Disease: Results From the Phase 3 ADVANCE and MOTIVATE Studies. (October 2021)

Authors:
Bossuyt, Peter; Ferrante, Marc; Baert, Filip; Danese, Silvio; Feagan, Brian; Loftus, Edward V.; Panés, Julian; Peyrin-Biroulet, Laurent; Ran, Zhihua; Armuzzi, Alessandro; D'Haens, Geert; Song, Alexandra; Neimark, Ezequiel; Liao, Xiaomei; Zhou, Qian; Berg, Sofie; Wallace, Kori; Panaccione, Remo
Journal:
American journal of gastroenterology
Issue:
Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1
Page Start:
S357
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗